CXCR3 and systemic sclerosis: For example, high concentrations of anti-CXCR3 aabs were found to predict a more benign clinical course of pulmonary disease in SSc (7), which is in contrast to anti-angiotensin and anti-endothelin receptor antibodies (13, 14).